Glutamatergic neurotransmission appears to be essential for generation of the eupneic pattern of inspiratory motor discharge as well as the expression of inspiratory-phase synchronization. The role of glutamatergic neurotransmission in the generation of gasping, including its accompanying modulation of spectral activity, is less well understood. The current investigation was, therefore, undertaken to investigate the effects of blockade of ionotropic glutamate receptors on (1) the generation and expression of gasping and (2) the magnitude and timing of spectral activity during gasping using an arterially-perfused decerebrate adult rat preparation. Our findings suggest that glutamatergic neurotransmission is not required for the production of gasping, but it may play a modulatory role in the expression of both the temporal and spectral characteristics of phrenic nerve discharge during gasping.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/978-0-387-73693-8_74 | DOI Listing |
Naunyn Schmiedebergs Arch Pharmacol
December 2024
Department of Pharmacology, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, Vile Parle (W), Mumbai, India.
Trace amines are physiologically active amines present in all organisms. They are structurally identical to traditional monoamines and are rapidly metabolized by monoamine oxidases. The mammalian neurological system generates these molecules at rates equivalent to traditional monoamines, but because of their short half-life, they are only observable in trace quantities.
View Article and Find Full Text PDFNeurosci Res
December 2024
Laboratory of Cellular Pharmacology, Graduate School of Pharmaceutical Sciences, Nagoya University, Nagoya, Japan; Laboratory of Neural Information Processing, Institute for Advanced Research, Nagoya University, Nagoya, Japan; PRESTO/CREST, Japan Science and Technology Agency, Saitama, Japan. Electronic address:
Despite the crucial role of synaptic connections and neural activity in the development and organization of cortical circuits, the mechanisms underlying the formation of functional synaptic connections in the developing human cerebral cortex remain unclear. We investigated the development of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR)-mediated synaptic transmission using human cortical organoids (hCOs) derived from induced pluripotent stem cells. Two-photon Ca⁺ imaging revealed an increase in the frequency and amplitude of spontaneous activity in hCOs on day 80 compared to day 50.
View Article and Find Full Text PDFNeural Regen Res
November 2025
School of Life Sciences, South China Normal University, Guangzhou, Guangdong Province, China.
JOURNAL/nrgr/04.03/01300535-202511000-00029/figure1/v/2024-12-20T164640Z/r/image-tiff Neuronal activity, synaptic transmission, and molecular changes in the basolateral amygdala play critical roles in fear memory. Cylindromatosis (CYLD) is a deubiquitinase that negatively regulates the nuclear factor kappa-B pathway.
View Article and Find Full Text PDFbioRxiv
December 2024
Department of Anesthesiology, Center for Clinical Pharmacology, Washington University Pain Center, Washington University School of Medicine, Washington University in St. Louis, St. Louis, MO, USA.
Distinct excitatory synaptic inputs to the locus coeruleus (LC) modulate behavioral flexibility. Here we identify a novel monosynaptic glutamatergic input to the LC from the ventral tegmental area (VTA). We show robust VTA axonal projections provide direct glutamatergic transmission to LC.
View Article and Find Full Text PDFSchizophrenia (Heidelb)
December 2024
CEINGE Biotecnologie Avanzate Franco Salvatore, Naples, Italy.
Schizophrenia (SCZ) is a severe psychotic disorder characterized by a disruption in glutamatergic NMDA receptor (NMDAR)-mediated neurotransmission. Compelling evidence has revealed that NMDAR activation is not limited to L-glutamate, L-aspartate, and glycine since other free amino acids (AAs) in the atypical D-configuration, such as D-aspartate and D-serine, also modulate this class of glutamatergic receptors. Although dysregulation of AAs modulating NMDARs has been previously reported in SCZ, it remains unclear whether distinct variations of these biomolecules occur during illness progression from at-risk premorbid to clinically manifest stage.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!